APT is developing Breakthrough Targeted Apheresis Absorbers to filter elevated pathogenic factors in blood to safely treat leading causes of mortality WW.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free